Scott Esecson

Scott Esecson is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as the Head of Strategic Business Leaders for the Central Area at argenx since April 2024. Prior to this role, Scott spent over 13 years at Genentech, progressing through various leadership positions including Senior Director of NeuroImmunology Marketing, where responsibilities included overseeing the marketing strategies for key products such as OCREVUS and ENSPRYNG. Scott has a solid background in oncology marketing, having led significant commercial initiatives and teams across multiple therapeutic areas. Previous experience includes roles at Eli Lilly, where achievements included the development of oncology marketing strategies and training programs. Scott holds an MBA from UCLA Anderson School of Management and a bachelor's degree in Business and Public Relations from the University of Southern California.